Watchmaker Genomics is a biotechnology company that focuses on breakthrough applications for reading, writing, and editing DNA.
Watchmaker Genomics has raised $40.0M in total funding. The most recent round was Series A. The last funding was announced in June 2022.
Watchmaker Genomics's investors include Eclipse, Decheng Capital.
Watchmaker Genomics is headquartered in Boulder, United States.
Watchmaker Genomics is a biotechnology company that focuses on breakthrough applications for reading, writing, and editing DNA.
Watchmaker Genomics is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Watchmaker Genomics — Funding & Investors." VCBacked, June 2, 2022, https://www.vcbacked.co/company/watchmaker-genomics. Accessed August 15, 2026.
VCBacked. (2022). Watchmaker Genomics — Funding & Investors. Retrieved August 15, 2026, from https://www.vcbacked.co/company/watchmaker-genomics
{{cite web |title=Watchmaker Genomics — Funding & Investors |url=https://www.vcbacked.co/company/watchmaker-genomics |website=VCBacked |access-date=August 15, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated